| Metric | Value | Detail |
|---|---|---|
| Revenue | $48.2B | -0.2% YoY |
| Net income | $7.1B | 14.6% margin |
| Gross margin | n/a | No gross profit line in the SEC data |
| Operating margin | n/a | No operating income line in the SEC data |
| Return on equity | 38% | Net income / equity |
| Return on assets | 8% | Net income / assets |
| Revenue growth (YoY) | -0.2% | FY2024 to FY2025 |
| Revenue 3-yr CAGR | +1.4% | Compound annual |
| Diluted EPS | $3.46 | FY2025 |
| Debt-to-equity | 2.32 | Long-term debt / equity |
| Current ratio | 1.26 | Current assets / liabilities |
| Cash & equivalents | $10.2B | Balance sheet |
| Total assets | $90.0B | FY2025 year-end |
| Shareholders’ equity | $18.5B | FY2025 year-end |
| Share price | $60.67 | Delayed · 2026-10-02 |
| Market cap | $123.9B | Price × shares outstanding |
| P/E ratio | 17.6 | Market cap / net income |
| P/S ratio | 2.6 | Market cap / revenue |
| Dividend yield | 4.10% | Dividend / price |
Stock fundamentals · FY2025 · SEC 10-K data
BRISTOL-MYERS SQUIBB COMPANY (BMY) stock fundamentals
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported $48.2B in revenue and $7.1B in net income in fiscal 2025, a 14.6% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $123.9B at a delayed share price. It scores 43/100 on WealthyBud's Investor Score, ranking #67 of 103 covered companies. Score is research, not investment advice.
BRISTOL-MYERS SQUIBB COMPANY fundamentals at a glance
The table summarizes BRISTOL-MYERS SQUIBB COMPANY's key financial figures for fiscal 2025 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.
How profitable is BRISTOL-MYERS SQUIBB COMPANY?
BRISTOL-MYERS SQUIBB COMPANY posted a 14.6% net margin in fiscal 2025, turning $48.2B of revenue into $7.1B of net income. Its return on equity was 38% and its return on assets 8%.
Is BRISTOL-MYERS SQUIBB COMPANY growing?
BRISTOL-MYERS SQUIBB COMPANY's revenue changed -0.2% in fiscal 2025 and compounded at +1.4% a year over three years, reaching $48.2B. Diluted earnings per share were $3.46 for the year.
| Fiscal year | Revenue | Growth |
|---|---|---|
| 2021 | $46.4B | First year shown |
| 2022 | $46.2B | -0.5% |
| 2023 | $45.0B | -2.5% |
| 2024 | $48.3B | +7.3% |
| 2025 | $48.2B | -0.2% |
How is BRISTOL-MYERS SQUIBB COMPANY valued?
BRISTOL-MYERS SQUIBB COMPANY carries a market capitalization of $123.9B at a delayed share price of $60.67. It trades at 17.6 times earnings and 2.6 times sales. Its dividend yield is 4.10%. Its Value subscore is 82/100 across the covered universe.
How financially healthy is BRISTOL-MYERS SQUIBB COMPANY?
BRISTOL-MYERS SQUIBB COMPANY ended fiscal 2025 with $10.2B in cash, a debt-to-equity ratio of 2.32 and a current ratio of 1.26. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.
What is BRISTOL-MYERS SQUIBB COMPANY's Investor Score?
BRISTOL-MYERS SQUIBB COMPANY scores 43/100 on WealthyBud's Investor Score, #67 of 103 covered companies as of 2026-10-02. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.
Subscores are percentile ranks (0–100) across the 103 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.
BRISTOL-MYERS SQUIBB COMPANY (BMY) stock FAQ
How much revenue does BRISTOL-MYERS SQUIBB COMPANY make?
Is BRISTOL-MYERS SQUIBB COMPANY profitable?
How fast is BRISTOL-MYERS SQUIBB COMPANY growing?
What is BRISTOL-MYERS SQUIBB COMPANY's market cap and P/E ratio?
What is BRISTOL-MYERS SQUIBB COMPANY's WealthyBud Investor Score?
Where does this BRISTOL-MYERS SQUIBB COMPANY financial data come from?
More large-cap stocks
PROGRESSIVE CORP (PGR)
$121.6B market cap · Investor Score 67/100
View StocksVERTEX PHARMACEUTICALS INC (VRTX)
$127.8B market cap · Investor Score 65/100
View StocksBooking Holdings Inc. (BKNG)
$119.3B market cap · Investor Score 67/100
View ResearchU.S. Stock Market Statistics (2026)
Market cap, valuation and concentration data across the U.S. stock market.
View